Arnold Paul, Banerjee S Preeya, Bhandari Rashmi, Lorch Elisa, Ivey Jennifer, Rose Michelle, Rosenberg David R
Department of Psychiatry, Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON, Canada.
Curr Psychiatry Rep. 2003 Aug;5(4):252-65. doi: 10.1007/s11920-003-0054-9.
Anxiety disorders are common disorders in childhood, and developmental differences must be considered when diagnosing and treating patients in this age group. Recent research has illuminated the course of childhood anxiety disorders, including how they can be precursors to continued anxiety and mood problems in adulthood. Recent studies of cognitive-behavioral therapy, the first-line psychosocial treatment for childhood anxiety, have focused on the following issues: the relative efficacy of group versus individual cognitive-behavioral therapy; the role of parent involvement; and the application of specific techniques to certain diagnostic groups (eg, social skills techniques in social phobia). Selective serotonin reuptake inhibitors have been associated with high acute response rates in controlled studies of children with anxiety disorders, and more recent evidence suggests they are efficacious and well tolerated when taken for longer periods. This article will review significant diagnostic and developmental issues, and highlight recent studies in psychosocial and pharmacologic therapies of pediatric anxiety disorders.
焦虑症是儿童期常见的疾病,在诊断和治疗这个年龄组的患者时必须考虑发育差异。最近的研究阐明了儿童焦虑症的病程,包括它们如何成为成年期持续焦虑和情绪问题的先兆。最近对认知行为疗法(儿童焦虑症的一线心理社会治疗方法)的研究集中在以下问题上:团体认知行为疗法与个体认知行为疗法的相对疗效;父母参与的作用;以及特定技术在某些诊断组中的应用(例如社交技能技术在社交恐惧症中的应用)。在焦虑症儿童的对照研究中,选择性5-羟色胺再摄取抑制剂与高急性反应率相关,最近的证据表明,长期服用时它们有效且耐受性良好。本文将回顾重要的诊断和发育问题,并重点介绍儿科焦虑症心理社会和药物治疗的最新研究。